Aronex Pharma (ARNX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Aronex Pharma (ARNX)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert Floyd who wrote (188)	11/17/1998 4:50:00 PM
From: Sam Lee	Read Replies (1) of 320

The best I can figure is that if we are in a $500 mil area and capture 20% and have a normal royalty stream of 32% then that is 32mil in annual cash flow or more than $2 per share with very little related expense . Plus atragen. So I say that Aronex will only improve over the next 2 years. My source says to hold b/c he sees a $20 stock in two years or less. Nice write up today in the business section of the Houston Chronicle. So I am hanging on. The big sweat was that Aronex might go broke. That is over. The next hurdle is how much will it make and I like dealing with that far better than not knowing if we are going broke.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next